LLS Community

Many of us are concerned about the state of the world right now. And many of us are also wondering: “How can I help?” Here’s one thing you can do: spend an hour with The Leukemia & Lymphoma Society (LLS) on Wednesday, May 6, 2020 at 2 PM EDT when we’ll host our first-ever Virtual Advocacy Town Hall. You’ll learn how you can advocate on behalf of blood cancer patients during this challenging time. LLS works to ensure policymakers at every level of government are addressing ...

Please join The Leukemia & Lymphoma Society for a webcast for patients and caregivers. We invite you to learn more about: -Treatment options for CLL -Side-effects management -Ways to effectively communicate with your healthcare team about quality-of-life issues Event Details Thursday, May 21, 2020 1 to 2:30 PM EDT Speaker Jennifer Woyach, MD Associate Professor Section Head, CLL and Hairy Cell Leukemia Associate Division Director for Clinical Research Divis...

The newest episode of The Bloodline with LLS focuses on What Blood Cancer Patients Need to Know about COVID-19. Listen Now by clicking HERE! What does the effect of the virus have on blood cancer patients? What are hospitals doing to ensure cancer patients can still get treatment during this pandemic? What makes COVID-19 so different than other viruses? Has there been any progress made regarding treatment for COVID-19? Join us on this episode as Alicia and Lizette speak with Ruben A. Mesa...

As COVID-19 continues to dramatically change the healthcare landscape across the country and the world, what important information do healthcare professionals need to know? In this special episode, Tobias M. Hohl, MD, PhD, Chief, Infectious Diseases Service at Memorial Sloan-Kettering Cancer Center in New York, discusses the biology of the disease, what makes it so contagious, the danger of asymptomatic individuals, the impact on the cancer patient population, and what healthcare professional...

A Q&A with Amy Burd, PhD, LLS Vice President of Research Strategy Today is AML World Awareness Day, a day to acknowledge the struggle to tackle one of the most challenging blood cancers, while shining a light on advances in the prevention, management and treatment of acute myeloid leukemia (AML). The Leukemia & Lymphoma Society (LLS) is playing a significant role in the progress of diagnosing and treating AML, a fast moving leukemia that starts in the bone marrow and require...

Here at The Leukemia & Lymphoma Society (LLS), we remain laser-focused on continuing to drive forward our mission. In fact, we are amplifying our efforts to help patients and caregivers access the care they need, during the coronavirus crisis and beyond. Thankfully, we have a vibrant community of dedicated volunteers across the country who are just as relentless as we are about making a difference in the lives of blood cancer patients and their families. During this challenging time, ...

The coronavirus (COVID-19) pandemic has been a challenging time for us all. It is especially so for cancer patients and survivors, who are at greater risk of getting sicker if they become infected with the virus because they might be immunocompromised. On top of that, many patients and caregivers are struggling with financial hardship due to the coronavirus crisis. We’re hearing from patients and caregivers who have lost their jobs, or who are furloughed while their companies temporarily...

Driving forward science While we all are navigating uncertainty and challenges in these unprecedented times, there is promising news: science is racing forward. Dedicated researchers around the world are collaborating in new ways, sharing data openly and advancing our understanding of the novel virus that causes coronavirus disease (COVID-19). In fact, more than 70 countries have joined the World Health Organization in accelerating research on effective treatments for COVID-19 and about 20...

As the coronavirus continues its spread, The Leukemia & Lymphoma Society (LLS) has a vital role to play in ensuring our government takes every step necessary to protect cancer patients. With that in mind, we’re sharing with our community what LLS has been doing to make sure the unique needs of blood cancer patients are being heard by the government at this unprecedented time. First, some background: LLS’s Office of Public Policy is focused on influencing the laws, regulations and r...

As a result of COVID-19, many cancer patients are receiving treatment in different facilities or from different providers to help slow the spread of the virus. Though these changes may be necessary, they can result in patients unknowingly receiving out-of-network care -- and potentially facing unexpected medical bills totaling thousands of dollars. #NoMoreSurprises Click here to TELL CONGRESS: ACT NOW TO PROTECT CANCER PATIENTS FROM COVID-19